SOLACI-SBHCI 2016 Presentations

Venus P-Valve: The valve and initial clinical worldwide experience

solaci
solaci
700
0

Por Dr. Alejandro Peirone.

Venus P Valve SOLACI
Previous article
FFR EM LESÕES SEQUENCIAIS E DOENÇA DIFUSA
Next article
BIODEGRADE: Does Stent Design Affect Long-Term Clinical Results?
solaci
solaci

More articles by this author

FFR EM LESÕES SEQUENCIAIS E DOENÇA DIFUSA

solaci - 0
Por Dr. Silvio Gioppato.  

Erros mais comuns na realização do FFR: como identificá-los e preveni-los

solaci - 0
Por Dr. Fernando Mendes Sant’Anna.  

Análise Crítica do Estudo Leaders É o melhor stent que temos?

solaci - 0
Por Dr. Esmeralci Ferreira.  

Contemporaneous approach of the left atrial appendage and patent oval foramen: when intervention is indicated

solaci - 0
Por Dr. Carlos Pedra.  

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 0
Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Dr. Juan Manuel Pérez - 0
Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Dr. Omar Tupayachi - 0
Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...